AstraZeneca and Daiichi Sankyo have claimed their seventh FDA approval for Enhertu, getting the go-ahead for the blockbuster drug as a second-line treatment for patients with HER2-low and HER2 ...
A US jury has decided that Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu infringes a patent held by US biotech Seagen, awarding almost $42 million in damages. Seagen claims Enhertu ( ...
A man accused of the brutal rape and murder of his wife at Murray Barracks on February 8th, 2025, has been arrested.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback